These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Lymphoma development in patients with autoimmune and inflammatory disorders--what are the driving forces? Baecklund E; Smedby KE; Sutton LA; Askling J; Rosenquist R Semin Cancer Biol; 2014 Feb; 24():61-70. PubMed ID: 24333759 [TBL] [Abstract][Full Text] [Related]
5. Excess of autoimmune and chronic inflammatory disorders in patients with lymphoma compared with all cancer patients: a cancer registry-based analysis in the south of the Netherlands. van de Schans SA; van Spronsen DJ; Hooijkaas H; Janssen-Heijnen ML; Coebergh JW Autoimmun Rev; 2011 Feb; 10(4):228-34. PubMed ID: 21074639 [TBL] [Abstract][Full Text] [Related]
6. Clinical features and outcome of lymphoma patients with pre-existing autoimmune diseases. Shih YH; Yang Y; Chang KH; Chen YH; Teng CJ Int J Rheum Dis; 2018 Jan; 21(1):93-101. PubMed ID: 29205866 [TBL] [Abstract][Full Text] [Related]
9. Prevalence and clinical impact of autoimmune diseases and chronic infections in malignant lymphomas at diagnosis. Vanura K; Späth F; Gleiss A; Le T; Porpaczy E; Skrabs C; Hauswirth A; Fleiss K; Wessely F; Gaiger A; Müllauer L; Jäger U Ann Hematol; 2011 Aug; 90(8):947-54. PubMed ID: 21327940 [TBL] [Abstract][Full Text] [Related]
10. High incidence of autoimmune disease in Japanese patients with ocular adnexal reactive lymphoid hyperplasia. Kubota T; Moritani S Am J Ophthalmol; 2007 Jul; 144(1):148-9. PubMed ID: 17601445 [TBL] [Abstract][Full Text] [Related]